The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study - Concepedia

Concepedia

Publication | Open Access

The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study

DOI Full Paper Access

21

Citations

16

References

2016

Year

Xavier Mariette, Rieke Alten, H. Nüßlein, Mauro Galeazzi, Hanns‐Martin Lorenz, Alain Cantagrel, M. Chartier, Coralie Poncet, C. Rauch, Manuela Le Bars

Joint Bone Spine

Abstract

BMI does not impact abatacept clinical response or retention in biologic-naïve patients with RA.

References

	Year	Citations

Page 1